Kazutaka Hosoya

4PUBLICATIONS

43CO-AUTHORS

Molecular targetsMedical infection agents (incl. prions)

Featured researcher

Get your video featured.

Publish with JoVE

Featured researcher

Get your video featured.

Publish with JoVE

Publications (4)

Sort by Publication Date:

|Jul 07, 2026

Anti-PD-1 plus anti-CTLA-4 blockade overcomes immune exclusion in NSCLC brain metastases by enhancing CD8+ T cell responses and promoting tertiary lymphoid structure formation.

|Dec 10, 2025

Microglia Display Heterogeneous Initial Responses to Disseminated Tumor Cells.

Takahiro Tsuji, Haruka Hirose, Daisuke Sugiyama

|Apr 09, 2025

Novel TEAD1 Inhibitor VT103 Enhances Dabrafenib Efficacy in BRAF V600E Mutated Lung Adenocarcinoma via Survivin Downregulation.

Kazutaka Hosoya, Hiroaki Ozasa, Hironori Yoshida

|Dec 05, 2023

Combination Therapy with EGFR Tyrosine Kinase Inhibitors and TEAD Inhibitor Increases Tumor Suppression Effects in EGFR Mutation-positive Lung Cancer.

Tatsuya Ogimoto, Hiroaki Ozasa, Takahiro Tsuji

Pageof 1

Frequent Collaborators

4 joint publications

Hiroaki Ozasa

4 joint publications

Takahiro Tsuji

3 joint publications

Akihiko Yoshizawa

3 joint publications

Kentaro Hashimoto

2 joint publications

Tatsuya Ogimoto

2 joint publications

Tomoko Funazo

2 joint publications

Hiroshi Yoshida

2 joint publications

Hitomi Ajimizu

2 joint publications

Takashi Nomizo

2 joint publications

Hironori Yoshida

Frequent Collaborators

4 joint publications

Hiroaki Ozasa

4 joint publications

Takahiro Tsuji

3 joint publications

Akihiko Yoshizawa

3 joint publications

Kentaro Hashimoto